Skip to main content

Pregnancy-related anxiety and its associated factors during COVID-19 pandemic in Iranian pregnant women: a web-based cross-sectional study



Pregnancy is a risk factor for coronavirus disease 2019 (COVID-19). Pregnant women suffer from varying levels of pregnancy-related anxiety (PRA) which can negatively affect pregnancy outcomes. The aim of this study was to assess PRA and its associated factors during the COVID-19 pandemic.


This web-based cross-sectional study was conducted in 2020 on 318 pregnant women purposively recruited from primary healthcare centers in Sari and Amol, Iran. Data were collected using questionnaires (PRAQ, Edinburg, KAP of COVID-19, CDA-Q and Demographic questionnaire), which were provided to participants through the social media or were completed for them over telephone. Data were analyzed with the linear regression and the logistic regression analysis, at the significance level of 0.05 using the SPSS software (v. 21).


Around 21% of participants had PRA, 42.1% had depression, and 4.4% had COVID-19 anxiety. The significant predictors of PRA were number of pregnancies (P = 0.008), practice regarding COVID-19 (P < 0.001), COVID-19 anxiety (P < 0.001), depression (P < 0.001), and social support (P = 0.025) which explained 19% of the total variance. Depression and COVID-19 anxiety increased the odds of PRA by respectively four times and 13%, while good practice regarding COVID-19 decreased the odds by 62%.


Around 21% of pregnant women suffer from PRA during the COVID-19 pandemic and the significant predictors of PRA during the pandemic include number of pregnancies, practice regarding COVID-19, COVID-19 anxiety, depression, and social support. These findings can be used to develop appropriate strategies for the management of mental health problems during pregnancy in the COVID-19 pandemic.

Peer Review reports


Pregnancy is among the most important events in women’s life. It is associated with many different physical, emotional, and social changes [1]. Besides, pregnant women are concerned with fetal growth and their future responsibilities and hence, are prone to varying levels of psychological problems such as mood changes, fatigue, emotional disorders, mixed anxiety-depressive disorder, and pregnancy-related anxiety (PRA) [2]. PRA is a common problem among women during and after pregnancy [3].

PRA is defined as concerns, preoccupations, and fears related to pregnancy, delivery, neonatal health, and childrearing [4]. Anxiety is a normal response in stressful conditions [5]. Accordingly, healthy levels of PRA help pregnant women adhere to health-related recommendations [6]. However, severe PRA can negatively affect women’s physical and mental health and their children’s cognitive, emotional, and behavioral development [2]. Different studies reported the relationship of PRA with health-related problems such as intrauterine growth restriction [7], premature birth [8], cleft lip and palate, still birth, neonatal death [9], autism, hyperactivity, and neurodevelopmental disorders [10]. The prevalence of PRA in developing countries is 10–25% [11]. Studies in Iran assessed PRA using general anxiety questionnaires and reported prevalence rates of 32.5 and 40% [12, 13].

A major source of PRA is affliction by infectious diseases [14], particularly during epidemics and pandemics. Pandemics affect people and communities at different levels and cause disturbances in communities. They challenge psychological resilience and are usually associated with horror, stress, anxiety, sleep disorders, and negative attitudes towards health [5]. Previous studies reported that affliction by viral infections during the epidemics of H1N1 influenza, Middle East Respiratory syndrome (MERS), and Severe Acute Respiratory Syndrome (SARS) caused pregnant women negative clinical outcomes such as death, spontaneous abortion, premature birth, and fetal death [15, 16].

Coronavirus disease 2019 (COVID-19) was first observed in December 2019 in Wuhan, China, and rapidly spread throughout the world [17]. In January 2020, the World Health Organization introduced it as an international crisis [18]. In Iran, COVID-19 was first reported in February and then, it affected many people around the country. The Ministry of Health of Iran reported that by the middle of October 2020, the number of patients with COVID-19 and the number of its associated deaths in Iran were more than 935,000 and 47,000, respectively ( This study was conducted during the first peak of COVID - 19 outbreak, when little information was available about the disease and ways of spread of COVID − 19 in population, and there was no extensive studies about the disease. There was any definitive treatment or any vaccine against the COVID-19 [19].

The risk factors for COVID-19 include impaired immunity, history of respiratory or cardiac disorders, cancer, aging, obesity, and pregnancy [6, 20]. However, there are little information about effect of COVID-19 in pregnancy [21], Pregnancy-related physiologic changes in the anatomy and the function of the lungs together with impaired immunity put pregnant women at great risk for affliction by COVID-19 [17]. During epidemics and pandemics, factors such as fear over affliction and death and disturbances in daily activities due to the necessity of quarantining cause varying levels of anxiety [17]. Uncertainties over transmission routes and doubts about national readiness for pandemic management affect people’s adherence to preventive measures and cause them psychological strains [22, 23]. The sources of concern and anxiety for pregnant women during pandemics include concern over quarantine-related loneliness during and after delivery, limited access to healthcare services due to fear over affliction, increased requests for delivery through elective Cesarean section, concerns related to the frequent use of disinfectants, and concerns over child care, breastfeeding, and vaccination [24].

A recent study on 178 pregnant women in Italy during the COVID-19 pandemic reported that 46.6% of them had anxiety due to their fear over potential fetal anomalies caused by COVID-19, 65% of them had fear over intrauterine growth restriction, and 51% of them had fear over premature birth [5]. Studies during the MERS pandemic also showed that 80% of afflicted patients experienced fear [25, 26], isolation, social stigmatization, anxiety and anger during the two-week course of quarantine period [26].

To the best of our knowledge, limited studies have assessed PRA during the COVID-19 pandemic and no study has yet assessed it during the pandemic using PRA-specific questionnaires. Therefore, the present study was conducted to address this gap. The aim of the study was to assess PRA and its associated factors during the COVID-19 pandemic.



This web-based cross-sectional descriptive-correlational study was conducted from April 17 to May 31, 2020.


Study population comprised all pregnant women referred to primary healthcare centers in Amol and Sari, Iran. Inclusion criteria were having a healthy pregnancy without history of COVID - 19 disease, access to social media or telephone, no history of stressful life events in the past 6 months (including divorce, marriage, or significant loss), no affliction by mental health disorders, and no intake of psychiatric medications. The only exclusion criterion was voluntary withdrawal from the study. Sampling was performed purposively.

The pergnant women who were included in the study had a complete health file in primary health care centers. For sampling, we referred to primary healthcare centers in Amol and Sari, Iran, and created a list of eligible women and their telephone numbers. Then, midwives in the study setting called eligible women over telephone, invited them to the study, provided them with the study instruments over the WhatsApp application, and asked them to complete them. Study instruments for participants with no access to the WhatsApp application were completed through telephone-based interviews. In order to have confidential questionnaire, one of the researchers (AAA) filled them by information obtained through the telephone interviews.

Based on the rule of thumb of fifteen participants per item [27], as the PRAQ has seventeen items, sample size was calculated to be 300.


Study instruments were a demographic and midwifery characteristics questionnaire, the Edinburgh Postnatal Depression Scale, the Pregnancy Related Anxiety Questionnaire, the Corona Disease Anxiety Questionnaire, and a COVID-19 knowledge, attitude, and practice questionnaire. The questionnaire was in Persian.

The demographic and midwifery characteristics questionnaire included items on age, educational level, place of residence, occupation, level of family support, financial status, pregnancy wantedness, number of pregnancies, route of previous deliveries, and history of abortion, premature birth, bleeding during pregnancy, gestational diabetes mellitus, hypertension, and placental disorders.

The Edinburgh Postnatal Depression Scale is used for depression assessment during pregnancy and after delivery [28]. It contains ten multiple-choice questions on depression severity scored 0–3 (items 1, 2, and 4) or 3–0 (items 3 and 5–10). The total score of the scale is 0–30 and respondent with scores more than 12.5 are considered to have depression [29]. A former study reported the acceptable validity of this scale [30].

The Pregnancy Related Anxiety Questionnaire assesses pregnancy-related fears and concerns [31]. The short form of this questionnaire has seventeen items scored on a seven-point scale from 1 (“Definitely not true”) to 7 (“Definitely true”). The possible total score of the questionnaire is 17–119 with higher scores indicating greater anxiety. There is no cutoff point for the score of this questionnaire, while people with scores ranging from 65 to 70% total scores considered to have anxiety [32]. In the present study, scores greater than 66.3 were interpreted as anxiety. This questionnaire has acceptable validity and reliability [31].

The COVID-19 knowledge, attitude, and practice questionnaire was a researcher-made questionnaire developed based on the protocols recommended by the World Health Organization and the Ministry of Health of Iran for COVID-19 prevention and management. The knowledge part of this questionnaire had thirteen items on the transmission routes and the methods for the prevention and management of COVID-19.The knowledge items were about the signs and symptoms of the COVID − 19, prevention of the COVID − 19, transmission of the COVID- 19 virus from mother to child during pregnancy, lactation during disease and treatment of the COVID − 19). Items were scored either zero (“No” or “I don’t know”) or 1 (“Yes), resulting in a possible total score of 0–13. Scores greater than 9 were interpreted as good knowledge about COVID-19. The attitude part of the questionnaire had two items on the controllability of the COVID-19 pandemic which were scored either zero (“Disagree” or “I don’t know”) or 1 (“Agree”). Therefore, the possible total score of the attitude part is 0–2 and score 2 shows good attitude. The practice part included three items on the use of gloves and facemask in outdoor areas and attendance at public places during the COVID-19 pandemic. Items were scored either zero (“Yes”) or 1 (“No”), resulting in a possible total score of 0–3 with score 3 showing good practice. The validity of this questionnaire was assessed through face and content validity assessments. Eleven experts rated the items, and the content validity indices (CVI) of the three parts of the questionnaire were calculated to be 0.81–1. The Cronbach’s alpha of the questionnaire was 0.79.

The Corona Disease Anxiety Questionnaire (CDA-Q) was developed in Iran with eighteen items on physical and mental anxiety. Items are scored on a four-point scale as follows: zero: “Never”; 1: “Sometimes”; 2: “Mostly”; and 3: “Always”. The possible total score of this question is 0–54 and respondents with scores greater than 37.8 are considered to have anxiety. This questionnaire has acceptable validity and reliability [33].

Data analysis

Data were analyzed using the SPSS software (v. 21.0). The measures of descriptive statistics were used for data description, while the linear regression analyses were used to determine the predictors of PRA. The logistic regression analyses were used to odd ratio of PRA. Since there were many variables in the study (City, Health Center, Age, Education, Residence, job, Husband job, Social support, Gravid, Abortion, Pre-term labor, Pain, Vaginal delivery, any medical history, Knowledge, Attitude, Practice, PRAQ, CDA-Q, Depression), variables which had relationship with PRA at a significance level of less than 0.2 were entered in the regression models. Data were analyzed at the significance level of 0.05.


During the two-month course of data collection, the study instrument was viewed 942 times and 318 pregnant women completed them (response rate: 53%). The mean of response time was 16 min and 96% of participants completed the instruments via the WhatsApp application. The flow chart participants’ recruitment showed in the Fig. 1.

Fig. 1

Flow chart of study

The mean of participants’ age was 28.57 ± 5.06 years and most of them had university degree (54.7%), were housewife (85.5%), lived in urban areas (67%), were primiparous (59.7%), and had good social support (50.6%) (Table 1).

Table 1 Participants’ demographic and midwifery characteristics

The mean scores of participants’ knowledge, attitudes, and practice regarding the COVID-19 pandemic were respectively 9.17 ± 2.02 (in the possible range of 0–13), 0.95 ± 0.86 (in the possible range of 0–2), and 2.59 ± 0.63 (in the possible range of 0–3). Moreover, the mean scores of their PRA, depression, and COVID-19 anxiety were respectively 44.64 ± 19.93 (in the possible range of 17–119), 12.16 ± 3.43 (in the possible range of 6–24), and 10.58 ± 8.51 (in the possible range of 0–45) (Table 2). Most participants had limited knowledge (53.1%), poor attitude (65.1%), and poor practice (66.7%) respecting COVID-19. Moreover, 20.8% of them had PRA, 42.1% had depression, and 4.4% had COVID-19 anxiety (Table 2).

Table 2 The mean scores of the main study outcomes

Linear regression analysis using the stepwise method showed that the significant predictors of PRA were number of pregnancies (P = 0.008), practice regarding COVID-19 (P < 0.001), COVID-19 anxiety (P < 0.001), depression (P < 0.001), and social support (P = 0.025). These variables explained 19% of the total variance of PRA mean score (Table 3).

Table 3 The results of linear regression analysis for PRA prediction

The logistic regression analysis also showed that the number of pregnancies (one vs. more), history of serious health problems (diabetes mellitus, renal disease, and hypertension vs. others or none), knowledge (score above 9) and practice respecting COVID-19 (good vs. poor), and COVID-19 anxiety (yes vs. no) were eligible variables for logistic regression analysis. The results of the analysis showed that depression increased the odds of PRA by four times (adjusted odds ratio: 4.298, 95% confidence interval: 2.161–8.546, P < 0.001) and COVID-19 anxiety increased the odds of PRA by 13% (adjusted odds ratio: 1.125, 95% confidence interval: 1.066–1.187, P < 0.001). Good practice respecting COVID-19 also decreased the odds of PRA by 62% (adjusted odds ratio: 0.379, 95% confidence interval: 0.188–0.765, P < 0.001) (Table 4).

Table 4 The results of logistic regression analysis to determine the odds of PRA


This study aimed to assess PRA and its predictors during the COVID-19 pandemic. Findings showed that almost 21% of the participants experienced PRA. This is in line with the findings of a former study in Iran [34]. In a systematic review a prevalence of anxiety was reported from 3.8 to 17.5% in Asian countries [35] .A study in China also showed that the prevalence of moderate to severe PRA was 28.8% [36]. The COVID-19 pandemic has reduced pregnant women’s access to routine prenatal care services due to factors such as rapid spread of the disease, lack of an effective treatment or vaccine, the necessity of quarantining and its subsequent loneliness during affliction, stigmatization and despair [37], and concerns over contamination with the virus in healthcare settings [11]. Moreover, it has caused pregnant women different psychological disorders due to the restriction of the number of companions in healthcare settings, concerns over the lack of workforce in maternity settings, limited access to specialized care services for women with suspected COVID-19 [38], and requests for pregnancy termination or elective Cesarean section surgery [39].

Findings showed that pregnant women with COVID-19 anxiety were 13% more likely to have PRA. Moreover, those with diabetes mellitus, renal disease, or hypertension were 3.6 times more at risk for PRA. Contrarily, participants with good practice respecting COVID-19 were 62% less likely to have PRA. These findings imply that the COVID-19 pandemic is a serious challenge for pregnant women. A former study in Iran also showed that pregnant women had higher levels of COVID-19 anxiety compared with their non-pregnant counterparts [40]. Another study in Iran revealed that pregnant women in the third trimester of pregnancy were concerned with COVID-19 disease and its consequences and had higher levels of anxiety. That study also reported that higher levels of anxiety among pregnant women during the COVID-19 pandemic might be due to their limited access to healthcare services, their concerns over the unsafe environment of healthcare settings, and concerns over affliction by the disease [34]. A study in Pakistan showed that 84% of pregnant women had fear over COVID-19 and the mean score of generalized anxiety disorder among women with fear over COVID-19 was significantly higher [41].

Our findings also showed the number of pregnancies as a significant predictor of PRA. Similarly, a former study found gravidity as a significant factor contributing to PRA symptoms and reported that nulliparous women had higher levels of PRA compared with their multiparous counterparts [42]. Moreover, we found that most participants had poor knowledge, attitude, and practice respecting COVID-19. Attitude and practice respecting COVID-19 are correlated with the level of knowledge [10, 43, 44]. Moreover, our findings showed that 42% of participants had depression. In a systematic review study the prevalence of depression was reported from 5.2 to 40% [35]. COVID-19 prevention largely depends on social distancing and quarantining [45] which in turn can cause social isolation, sadness, worries, anger, irritability, despair [46] and increasing level of domestic violence [35]. Studies on the general population in China reported that almost one third of them had depressive symptoms [47] and women had higher levels of depression and anxiety [18]. A study also showed that depressive symptoms have increased during the COVID-19 pandemic [42]. Anxiety and depression during the perinatal period are associated with depression in later years of life [48]. Moreover, PRA can increase the risk of antenatal depression [49] and pregnancy-related complications such as preterm birth [50]. Contrary to our findings, a former study reported no significant difference in depression rate among pregnant women before and after the SARS outbreak [8]. A study in Iran also showed no significant difference among non-pregnant, pregnant, and breastfeeding women regarding depression rate during the COVID-19 pandemic [40].

Strengths and limitations

One of the main strengths of the present study was web-based sampling and data collection which helped us collect the necessary data without exposing participants to COVID-19. However, web-based data collection can increase the risk of biases [51]. For instance, as people with better socioeconomic status may have better access to social media, web-based data collection may be associated with some levels of selection bias. We attempted to prevent and manage this bias through telephone-based data collection from participants with limited access to social media. There is a data collection limitation. Data collection through telephone may also associate with bias at data assessor level. As the total number of participants that completed the questionnaire via telephone were 17 person, it didn’t seem to affect the results of the study. This study was done in a cross-sectional mode that does not show any causal relationship between variables.


This study shows that around 21% of pregnant women suffer from PRA during the COVID-19 pandemic and the significant predictors of PRA during the pandemic include number of pregnancies, practice regarding COVID-19, COVID-19 anxiety, depression, and social support. Although the effects of COVID-19 on pregnancy outcomes are still unknown, COVID-19 can negatively affect pregnancy outcomes through causing different mental health problems such as anxiety. Lack of definitive treatment of COVID-19, limited information on the effect of the disease on pregnant mother and neonate, uncertainty about how long the quarantine is to be in action, fear of attending hospital and health care centers were some reasons on anxiety during quarantine COVID-19.


Healthcare authorities can use the findings of the present study to accurately identify pregnant women who are at higher risk for PRA and employ strategies to reduce their PRA through improving their knowledge, attitude, and practice regarding pandemics.

Availability of data and materials

The datasets analyzed during the current study are available from the corresponding author on reasonable request.



Coronavirus disease 2019


Pregnancy-related anxiety


Middle East Respiratory syndrome


Severe Acute Respiratory Syndrome


Statistical Package for Social Sciences


Standard Deviation


Adjusted Odd Ratio


Confidence Interval


  1. 1.

    Ahmadi A, Moosavi Sahebalzamani S, Ghavami F, Shafiee Y, Fathi AA. Effects of psychological interventions on postpartum depression, anxiety and infants' weight in primipara women. Prev Care Nurs Midwifery J. 2014;4(1):19–31.

    Google Scholar 

  2. 2.

    Bjelica A, Cetkovic N, Trninic-Pjevic A, Mladenovic-Segedi L. The phenomenon of pregnancy—a psychological view. Ginekol Pol. 2018;89(2):102–6.

    Article  Google Scholar 

  3. 3.

    Chinchilla-Ochoa D, Peón PB-C, Farfán-Labonne BE, Garza-Morales S, Leff-Gelman P, Flores-Ramos M. Depressive symptoms in pregnant women with high trait and state anxiety during pregnancy and postpartum. Int J Women's Health. 2019;11:257.

    Article  Google Scholar 

  4. 4.

    Littleton HL, Breitkopf CR, Berenson AB. Correlates of anxiety symptoms during pregnancy and association with perinatal outcomes: a meta-analysis. Am J Obstet Gynecol. 2007;196(5):424–32.

    Article  Google Scholar 

  5. 5.

    Mappa I, Distefano FA, Rizzo G. Effects of coronavirus 19 pandemic on maternal anxiety during pregnancy: a prospectic observational study. J Perinat Med. 2020;48(6):545–50.

    CAS  Article  Google Scholar 

  6. 6.

    Mirzadeh M, Khedmat L. Pregnant women in the exposure to COVID-19 infection outbreak: the unseen risk factors and preventive healthcare patterns. J Matern Fetal Neonatal Med. 2020:1–2.

  7. 7.

    Seyed Ahmadi Nejad FS, Golmakani N, Asghari Pour N, Shakeri MT. Effect of progressive muscle relaxation on depression, anxiety, and stress of primigravid women. Evid Based Care. 2015;5(1):67–76.

    Google Scholar 

  8. 8.

    Loomans EM, Van Dijk AE, Vrijkotte TG, Van Eijsden M, Stronks K, Gemke RJ, et al. Psychosocial stress during pregnancy is related to adverse birth outcomes: results from a large multi-ethnic community-based birth cohort. Eur J Pub Health. 2013;23(3):485–91.

    Article  Google Scholar 

  9. 9.

    Fischbein RL, Nicholas L, Kingsbury DM, Falletta LM, Baughman KR, VanGeest J. State anxiety in pregnancies affected by obstetric complications: a systematic review. J Affect Disord. 2019;257:214–40.

    Article  Google Scholar 

  10. 10.

    Ranjan R, Ranjan GK. Knowledge regarding prevention of novel coronavirus (COVID-19): an electronic cross-sectional survey among selected rural community. Int J Trend Sci Res Dev. 2020;4(3):422-6.

  11. 11.

    Martini J, Petzoldt J, Einsle F, Beesdo-Baum K, Höfler M, Wittchen H-U. Risk factors and course patterns of anxiety and depressive disorders during pregnancy and after delivery: a prospective-longitudinal study. J Affect Disord. 2015;175:385–95.

    Article  Google Scholar 

  12. 12.

    Zareipour M, Sadaghianifar A, Amirzehni J, Parsnezhad M, Ayuoghi RV. Exploring of depression, anxiety and stress in pregnant women referred to health centers of Urmia. Rahavard Salamat J. 2018;3(2):19–30.

    Google Scholar 

  13. 13.

    Sadeghi N, Azizi S, Molaeinezhad M. Anxiety status in pregnant mothers at third trimester of pregnancy and its related factors in referrals to Bandar Abbas Hospitals in 2012. Iran J Obstet Gynecol Infertil. 2014;17(122):8–15.

    Google Scholar 

  14. 14.

    Soto-Balbuena C, Rodriguez M, Escudero Gomis AI, Ferrer Barriendos FJ, Le H-N, Pmb-Huca G. Incidence, prevalence and risk factors related to anxiety symptoms during pregnancy. Psicothema. 2018;30(3):257–63.

    PubMed  Google Scholar 

  15. 15.

    Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.

    CAS  Article  Google Scholar 

  16. 16.

    Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020.

  17. 17.

    Haghdoost SM, Gol MK. The necessity of paying more attention to the neurological and psychological problems caused by COVID-19 pandemic during pregnancy. Int J Womens Health Reprod Sci 2020;8(3):243–244.

  18. 18.

    Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–3.

    CAS  Article  Google Scholar 

  19. 19.

    Firouzbakht M, Omidvar S, Firouzbakht S, Asadi Amoli A. COVID-19 preventive behaviors and influencing factors in the Iranian population; a web-based survey. BMC Public Health. 2021;143:1–7.

    Google Scholar 

  20. 20.

    Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and metaanalysis. J Infect. 2020;81(2):e16-e25.

  21. 21.

    Zanardo V, Manghina V, Giliberti L, Vettore M, Severino L, Straface G. Psychological impact of COVID‐19 quarantine measures in northeastern Italy on mothers in the immediate postpartum period. Int J Gynecol Obstet. 2020;150(2):184-8.

  22. 22.

    Kamate SK, Agrawal A, Chaudhary H, Singh K, Mishra P, Asawa K. Public knowledge, attitude and behavioural changes in an Indian population during the influenza a (H1N1) outbreak. J Infect Develop Countries. 2010;4(01):007–14.

    Article  Google Scholar 

  23. 23.

    Al Najjar N, Attar L, Farahat F, Al TA. Psychobehavioural responses to the 2014 Middle East respiratory syndrome-novel corona virus [MERS CoV] among adults in two shopping malls in Jeddah, western Saudi Arabia. EMHJ-East Mediterr Health J. 2016;22(11):817–23.

    Article  Google Scholar 

  24. 24.

    Fakari FR, Simbar M. Coronavirus pandemic and worries during pregnancy; a letter to editor. Arch Acad Emerg Med. 2020;8(1):e21–e.

    Google Scholar 

  25. 25.

    Lee D, Kim J, Kang H. The emotional distress and fear of contagion related to Middle East respiratory syndrome (MERS) on general public in Korea. Korean J Psychol Gen. 2016;35(2):355–83.

    Article  Google Scholar 

  26. 26.

    Jeong H, Yim HW, Song Y-J, Ki M, Min J-A, Cho J, et al. Mental health status of people isolated due to Middle East respiratory syndrome. Epidemiol Health. 2016;38.

  27. 27.

    Hair JF, Black WC, Babin BJ, Anderson RE, Tatham R. Multivariate Data Analysis: Pearson Education. New Jersey: Pretince Hall; 2016.

  28. 28.

    Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh postnatal depression scale. Br J Psychiatry. 1987;150(6):782–6.

    CAS  Article  Google Scholar 

  29. 29.

    Rasouli P, Shobeiri F, Cheraghi F, Rasouli R, Ghanbari V. Study of the relationship of anxiety and depression in third trimester pregnancy on growth index of neonates and preterm delivery. J Pediatr Nurs. 2016;2(4):1–9.

    Google Scholar 

  30. 30.

    Ahmadi kani Golzar A, GoliZadeh Z. Validation of Edinburgh postpartum depression scale (EPDS) for screening postpartum depression in Iran. Iran J Psychiat Nurs. 2015;3(3):1–10.

    Google Scholar 

  31. 31.

    Van den Bergh PhD B. The influence of maternal emotions during pregnancy on fetal and neonatal behavior. J Prenatal Perinatal Psychol Health. 1990;5(2):119.

    Google Scholar 

  32. 32.

    Karamoozian M, Askarizadeh G, Behroozi N. The study of psychometric properties of pregnancy related anxiety questionnaire. J Clin Nurs Midwifery. 2017;5(4):22-34.

  33. 33.

    Alipour A, Ghadami A, Alipour Z, Abdollahzadeh H. Preliminary validation of the Corona disease anxiety scale (CDAS) in the Iranian sample; 2020.

    Google Scholar 

  34. 34.

    Saadati N, Afshari P, Boostani H, Beheshtinasab M, Abedi P, Maraghi E. Health anxiety of pregnant women and its related factors during the pandemic of Corona virus; 2020.

    Google Scholar 

  35. 35.

    Rahimi R, Dolatabadi Z, Moeindarbary S, Behzadfar S, Fakhr Ghasemi N, Tafrishi R, et al. A systematic review of the prevalence of mental health disorders in pregnant women during the COVID-19 pandemic. Int J Pediatr. 2020;8(11):12397–407.

    CAS  Google Scholar 

  36. 36.

    Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020;17(5):1729.

    CAS  Article  Google Scholar 

  37. 37.

    Shahyad S, Mohammadi MT. Psychological impacts of Covid-19 outbreak on mental health status of society individuals: a narrative review. J Mil Med. 2020;22(2):184-92.

  38. 38.

    Jiang H, Jin L, Qian X, Xiong X, La X, Chen W, Yang X, Yang F, Zhang X, Abudukelimu N, Li X. Evidence of accessing antenatal care information via social media platforms supports mental wellbeing in COVID-19 epidemic. Bull World Health Organ. 2020.

  39. 39.

    Ding X-X, Wu Y-L, Xu S-J, Zhu R-P, Jia X-M, Zhang S-F, et al. Maternal anxiety during pregnancy and adverse birth outcomes: a systematic review and meta-analysis of prospective cohort studies. J Affect Disord. 2014;159:103–10.

    Article  Google Scholar 

  40. 40.

    Gharagozloo M, Sadatmahalleh SJ, Khomami MB, Moini A, Kazemnejad A. Mental health and marital satisfaction changes of pregnant and lactating women during the COVID-19 pandemic; 2020.

    Book  Google Scholar 

  41. 41.

    Hossain N, Samuel M, Sandeep R, Imtiaz S, Zaheer S. Perceptions, Generalized Anxiety and Fears of Pregnant women about Corona Virus infection in the heart of Pandemic; 2020.

    Book  Google Scholar 

  42. 42.

    Lebel C, MacKinnon A, Bagshawe M, Tomfohr-Madsen L, Giesbrecht G. Elevated depression and anxiety among pregnant individuals during the COVID-19 pandemic; 2020.

    Google Scholar 

  43. 43.

    Zhong B-L, Luo W, Li H-M, Zhang Q-Q, Liu X-G, Li W-T, et al. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey. Int J Biol Sci. 2020;16(10):1745.

    Article  Google Scholar 

  44. 44.

    Anikwe CC, Ogah CO, Anikwe IH, Okorochukwu BC, Ikeoha CC. Coronavirus disease 2019: knowledge, attitude, and practice of pregnant women in a tertiary hospital in Abakaliki, Southeast Nigeria. Int J Gynecol Obstet. 2020;151(2):197–202.

    CAS  Article  Google Scholar 

  45. 45.

    Armitage R, Nellums LB. COVID-19 and the consequences of isolating the elderly. Lancet Public Health. 2020;5(5):e256.

    Article  Google Scholar 

  46. 46.

    Ren S-Y, Gao R-D, Chen Y-L. Fear can be more harmful than the severe acute respiratory syndrome coronavirus 2 in controlling the corona virus disease 2019 epidemic. World J Clin Cases. 2020;8(4):652.

    Article  Google Scholar 

  47. 47.

    Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based crosssectional survey. Psychiatry Res. 2020;288:112954.

  48. 48.

    Sutter-Dallay AL, Giaconne-Marcesche V, Glatigny-Dallay E, Verdoux H. Women with anxiety disorders during pregnancy are at increased risk of intense postnatal depressive symptoms: a prospective survey of the MATQUID cohort. Eur Psychiatry. 2004;19(8):459–63.

    CAS  Article  Google Scholar 

  49. 49.

    Rwakarema M, Premji SS, Nyanza EC, Riziki P, Palacios-Derflingher L. Antenatal depression is associated with pregnancy-related anxiety, partner relations, and wealth in women in northern Tanzania: a cross-sectional study. BMC Womens Health. 2015;15(1):68.

    Article  Google Scholar 

  50. 50.

    Brouwers EP, van Baar AL, Pop VJ. Does the Edinburgh postnatal depression scale measure anxiety? J Psychosom Res. 2001;51(5):659–63.

    CAS  Article  Google Scholar 

  51. 51.

    Kajdy A, Feduniw S, Ajdacka U, Modzelewski J, Baranowska B, Sys D, Pokropek A, Pawlicka P, Kaźmierczak M, Rabijewski M, Jasiak H. Risk factors for anxiety and depression among pregnant women during the COVID-19 pandemic: A web-based cross-sectional survey. Med. 2020;99(30):e21279.

Download references


The authors would like to thank deputy of research of Mazandaran university of medical sciences for supporting them to this study, and thanks all pregnant women who participated in the study as well as all midwives in the study setting who helped us in data collection.


This study funded by vice chancellor of research and technology Mazandaran University of Medical Sciences.

Author information




ZH and MF: study conception and design. MF, ZH and SO: Analysis and interpretation of data. ZH, MF, SO and AAA: Drafting of manuscript. ZH, MF, SO and AAA: Critical revision. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mojgan Firouzbakht.

Ethics declarations

Ethics approval and consent to participate

The Ethics Committee of Mazandaran University of Medical Sciences, Sari, Iran, approved this study (code: IR.MAZUMS.REC.1399.7390). We confirm all methods were performed in accordance with the relevant guidelines and regulations. We confirm that written informed consent for study participations and all the explanations were displayed in the first page of the questionnaire. Questionnaires were anonymous.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hamzehgardeshi, Z., Omidvar, S., Amoli, A.A. et al. Pregnancy-related anxiety and its associated factors during COVID-19 pandemic in Iranian pregnant women: a web-based cross-sectional study. BMC Pregnancy Childbirth 21, 208 (2021).

Download citation


  • Coronavirus disease 2019
  • Pandemic
  • Pregnancy-related anxiety